Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidences
about
Diet, Microbiota, Obesity, and NAFLD: A Dangerous QuartetDietary habits and behaviors associated with nonalcoholic fatty liver diseaseEffects of resveratrol in experimental and clinical non-alcoholic fatty liver diseaseModern approach to the clinical management of non-alcoholic fatty liver diseaseBile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications.Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications.Non-alcoholic fatty liver disease, diet and gut microbiota.The Effect of Symbiotic Supplementation on Liver Enzymes, C-reactive Protein and Ultrasound Findings in Patients with Non-alcoholic Fatty Liver Disease: A Clinical TrialPrediction and Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) and Identification of Its Associated Factors Using the Classification Tree Method.Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview.Non-alcoholic fatty liver disease in 2016.Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment.More on current evidences on probiotics as a novel treatment for non-alcoholic Fatty liver disease.Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.
P2860
Q26752614-11263CD7-8E5C-4B80-92AE-13756EC01CA2Q26830594-316C62C9-779A-42B7-9CD7-8C70D4CEF436Q33563877-3E19A42A-B10F-4B63-AB87-50CEA2E3D5A1Q33886923-917E5DDD-BD63-4165-9D80-104E07C8D718Q34425909-4400B8E0-83CD-44CC-AAFF-B22A95786CBEQ34589700-2FDE064A-58FE-47B9-9A0F-A77846A5F9A7Q34647400-3E13713F-C124-4F1E-BC1B-17FE6B4A3516Q35084719-A7657818-BB87-4A3A-996D-F15E1889A6DCQ35728214-4F261815-F7A3-4D0C-982B-B0AA8A32B02DQ36732958-23B6F27E-BA1C-4538-8C82-AB0D3698338FQ37625823-49858BE0-66C6-4955-B34E-F3741DA768E1Q38782562-00CBCE46-F4F9-42E1-8560-CA1BD90731D5Q38932554-DCA3DC55-AD08-4656-9A19-E9712399D348Q41158897-8EB0F0DB-7DB3-4A38-90B9-F98A96B7CF2EQ42083796-8E576E0E-C204-49D2-8B5D-1C39B89167A4Q47116789-F61400BD-C8E4-433C-918D-C8021122D475
P2860
Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidences
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Probiotics as a novel treatmen ...... eview on the current evidences
@en
Probiotics as a novel treatmen ...... view on the current evidences.
@nl
type
label
Probiotics as a novel treatmen ...... eview on the current evidences
@en
Probiotics as a novel treatmen ...... view on the current evidences.
@nl
prefLabel
Probiotics as a novel treatmen ...... eview on the current evidences
@en
Probiotics as a novel treatmen ...... view on the current evidences.
@nl
P2860
P356
P1433
P1476
Probiotics as a novel treatmen ...... eview on the current evidences
@en
P2093
Maryam Mirlohi
Sanam Farajian
P2860
P356
10.5812/HEPATMON.7233
P407
P577
2013-04-09T00:00:00Z